ERBB2 and breast carcinoma: The stage 3 palbociclib continuing trial in the handling of Breast Cancer (PALOMA)-238 study investigated the effectiveness of palbociclib along with letrozole against letrozole-only in postmenopausal female with HER2-negative and ER-positive progressive breast cancer.57